CMS-Run Medicaid Purchasing Pools For High-Cost Drugs Floated In Budget
Administration’s proposal to increase Medicaid leverage via more “unified” approach adds another idea to drug-pricing debates, though it would require legislation.
You may also be interested in...
An exchange during HHS Secretary Burwell’s testimony to the Finance Committee on the fiscal 2017 budget speaks volumes about what is – and is not – on the table for the last year of the Obama Administration.
CMS requests information from hepatitis C manufacturers on how value-based purchasing arrangements might work in Medicaid. Agency also urges state Medicaid directors to relax overly strict coverage requirements for the drugs.
Elizabeth Fowler brings combination of Capitol Hill, White House and pharma industry experience to the role of director of the Center for Medicare and Medicaid Innovation.